Evidence map›Paper›PMID 24376535›Full record

ArticlePloS one2013

Markers of T cell infiltration and function associate with favorable outcome in vascularized high-grade serous ovarian carcinoma.

Katelin N Townsend, Jaeline E Spowart, Hassan Huwait, Sima Eshragh, Nathan R West, Mary A Elrick, Steve E Kalloger, Michael Anglesio, Peter H Watson, David G Huntsman and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Cancer vaccines.BMJ (Clinical research ed.) · 2015
    Review
  13. Article
  14. T-cell intracellular antigens in health and disease.Cell cycle (Georgetown, Tex.) · 2015
    Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Katelin N TownsendTrev and Joyce Deeley Research Centre, British Columbia Cancer Agency, Victoria, British Columbia, Canada ; Department of Biochemistry and Microbiology, University of Victoria, Victoria, British Columbia, Canada.
Jaeline E SpowartTrev and Joyce Deeley Research Centre, British Columbia Cancer Agency, Victoria, British Columbia, Canada ; Department of Biochemistry and Microbiology, University of Victoria, Victoria, British Columbia, Canada.
Hassan HuwaitAnatomical Pathology, Vancouver General Hospital, Vancouver, British Columbia, Canada.
Sima EshraghDepartment of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Nathan R WestTrev and Joyce Deeley Research Centre, British Columbia Cancer Agency, Victoria, British Columbia, Canada ; Department of Biochemistry and Microbiology, University of Victoria, Victoria, British Columbia, Canada.
Mary A ElrickTrev and Joyce Deeley Research Centre, British Columbia Cancer Agency, Victoria, British Columbia, Canada ; Department of Biology, University of Victoria, Victoria, British Columbia, Canada.
Steve E KallogerDepartment of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Michael AnglesioDepartment of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Peter H WatsonTrev and Joyce Deeley Research Centre, British Columbia Cancer Agency, Victoria, British Columbia, Canada ; Department of Biochemistry and Microbiology, University of Victoria, Victoria, British Columbia, Canada ; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
David G HuntsmanCentre for the Translational & Applied Genomics, British Columbia Cancer Agency, Vancouver, British Columbia, Canada.
Julian J LumTrev and Joyce Deeley Research Centre, British Columbia Cancer Agency, Victoria, British Columbia, Canada ; Department of Biochemistry and Microbiology, University of Victoria, Victoria, British Columbia, Canada ; Department of Biology, University of Victoria, Victoria, British Columbia, Canada.
University of Victoria · CABC Cancer Agency · CAUniversity of British Columbia · CAVancouver General Hospital · CA

Funding

Canadian Institutes of Health Research MOP201945Canadian Institutes of Health Research MSH191375
6 · The paper itself

Abstract

backgroundWhen T cells infiltrate the tumor environment they encounter a myriad of metabolic stressors including hypoxia. Overcoming the limitations imposed by an inadequate tumor vasculature that contributes to these stressors may be a crucial step to immune cells mounting an effective anti-tumor response. We sought to determine whether the functional capacity of tumor infiltrating lymphocytes (TIL) could be influenced by the tumor vasculature and correlated this with survival in patients with ovarian cancer. METHODOLOGY AND PRINCIPAL

findingsIn 196 high-grade serous ovarian tumors, we confirmed that the tumor vascularity as measured by the marker CD31 was associated with improved patient disease-specific survival. We also found that tumors positive for markers of TIL (CD8, CD4 and forkhead box P3 (FoxP3)) and T cell function (granzyme B and T-cell restricted intracellular antigen-1 (TIA-1)) correlated significantly with elevated vascularity. In vitro, hypoxic CD8 T cells showed reduced cytolytic activity, secreted less effector cytokines and upregulated autophagy. Survival analysis revealed that patients had a significant improvement in disease-specific survival when FoxP3 expressing cells were present in CD31-high tumors compared to patients with FoxP3 expressing cells in CD31-low tumors [HR: 2.314 (95% CI 1.049-5.106); p = 0.0377]. Patients with high vascular endothelial growth factor (VEGF) expressing tumors containing granzyme B positive cells had improved survival compared to patients with granzyme B positive cells in VEGF-low tumors [HR: 2.522 (95% CI 1.097-5.799); p = 0.0294]. SIGNIFICANCE: Overall, this data provides a rationale for developing strategies aimed at improving the adaptability and function of TIL to hypoxic tumor conditions.

Indexed as

AdultAgedAged, 80 and overAnimalsAutophagyBiomarkers, TumorCD8-Positive T-LymphocytesCell HypoxiaCystadenocarcinoma, SerousFemaleFollow-Up StudiesGranzymesHumansLymphocytes, Tumor-InfiltratingMiceMiddle AgedBiomarkers, TumorGranzymesPlatelet Endothelial Cell Adhesion Molecule-1Poly(A)-Binding ProteinsT-Cell Intracellular Antigen-1TIA1 protein, human

Identifiers

PMID24376535
PMCPMC3871161
OpenAlexW1971998672

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.